NewEdge Advisors’s Avanos Medical AVNS Stock Holding History

NewEdge Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$546K	Sell	39,004 -9,994	-20%	-$135K	﹤0.01%	1915
2025 Q4	$550K	Buy	48,998 +48,865	+36,741%	+$559K	﹤0.01%	1899
2025 Q3	$1.54K	Hold	133	–	–	﹤0.01%	3826
2025 Q2	$1.63K	Sell	133 -22	-14%	-$277	﹤0.01%	3656
2025 Q1	$2.22K	Sell	155 -13	-8%	-$203	﹤0.01%	3486
2024 Q4	$2.67K	Hold	168	–	–	﹤0.01%	3396
2024 Q3	$4.04K	Hold	168	–	–	﹤0.01%	3217
2024 Q2	$3.35K	Hold	168	–	–	﹤0.01%	3207
2024 Q1	$3.35K	Sell	168 -8	-5%	-$155	﹤0.01%	3272
2023 Q4	$3.95K	Buy	176 +30	+21%	+$619	﹤0.01%	3188
2023 Q3	$2.95K	Hold	146	–	–	﹤0.01%	2955
2023 Q2	$3.73K	Hold	146	–	–	﹤0.01%	2903
2023 Q1	$4.34K	Sell	146 -9	-6%	-$261	﹤0.01%	2824
2022 Q4	$248	Buy	+155	New	+$3.79K	﹤0.01%	3273

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

NewEdge Advisors's AVNS Position: Q1 2026 in Review

NewEdge Advisors reduced its Avanos Medical (AVNS) stake by 20% in Q1 2026, selling an estimated $135K and leaving 39,004 shares worth $546K. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

NewEdge Advisors first reported a position in AVNS in Q4 2022 and has held it in 14 quarters since. The position peaked at $550K in Q4 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

NewEdge Advisors held 39,004 shares of Avanos Medical worth $546K as of Q1 2026.
NewEdge Advisors sold 9,994 Avanos Medical shares in Q1 2026, an estimated $135K.
Avanos Medical made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #1915 holding.
NewEdge Advisors first reported a position in Avanos Medical in Q4 2022 and has held it in 14 quarters since.
NewEdge Advisors's Avanos Medical position peaked at $550K in Q4 2025.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.